Ben M. Hause’s career has included positions in both industry and academia. Following completion of his MS degree from the University of Minnesota, he served as the Director of Diagnostic Services for Newport Laboratories while working toward his PhD in Biological and Biomedical Sciences from South Dakota State University. After receiving his doctorate, he pursued his research interests as an assistant professor at Kansas State University before returning to South Dakota State University as both an assistant professor and the section head of Virology. At Cambridge Technologies, Worthington, MN, USA, he keeps the company on the leading edge of animal health solutions through his work in the discovery and characterization of emerging livestock viruses and the development of vaccine countermeasures.
Juliana B. Ferreira is a Clinical Associate Professor at the Swine Health and
Production Medicine at NC State University. She received her DVM degree in
2002 from Universidade Metodista de São Paulo, Brazil, a Master of
Veterinary Medicine degree in 2005 in Epidemiology applied to zoonosis from
FMVZ–USP, Brazil, and a DVSc in Swine Health Management from the Ontario
Veterinary College, Guelph, Canada (2017). She also worked for 4 years for
the Public Health department in Brazil. Her research interests include swine
health and production, infectious diseases, and epidemiology. Teaching
responsibilities include veterinary and undergraduate courses.
Glen W Almond is a Professor at the Swine Health and Production Medicine and the Department of Population Health and Pathobiology, College of Veterinary Medicine, North Carolina State University, Raleigh, NC, USA. He earned, a DVM at the Ontario Veterinary College, Guelph, and a Ph.D. at the North Carolina State University. His research interests include porcine reproduction and anemia.
Anne S. De Groot M.D. has been CEO of EpiVax since founding the company in 1998 (27 years). In 2025, she will step back into the CMO position. She retains her position as CEO and co-founder of EpiVax Therapeutics, a translational biotechnology company that is a subsidiary of EpiVax, Inc. She earned an MD at the University of Chicago Pritzker School of Medicine (1983). She was formerly Professor (Research) and Senior Scientist at the University of Georgia from 2020 to 2023, Director of the Institute for Immunology and Informatics at the University of Rhode Island from 2009 to 2019, and faculty at the Brown University School of Medicine from 1993-2008. She is one of the founders and was the Volunteer Medical Director of Clinica Esperanza from 2008 to 2023, and remains on the Board of Directors. She was also founder and intermittently serves as Executive Director and/or Scientific Director of GAIA Vaccine Foundation from 2003 until the present. Her research interests include cellular immunology, vaccines, T lymphocytes, and immunology of infectious diseases, as well as public health, vaccine acceptance, and immunogenicity in general.
Gustavo Machado is an Associate Professor at the North Carolina State University, Raleigh, NC, USA. He is also an infectious disease modeler with expertise in food animal production epidemiology and the development of novel disease control strategies at multiple scales to reduce the burden of endemic and emerging diseases. His research interests include the epidemiology of transboundary diseases.
Elisa Crisci is an Assistant Professor in Virology at the College of Veterinary Medicine, North Carolina State University, Raleigh, NC, USA. She studied Veterinary Medicine at the University of Bologna (Italy) and earned her MSc and Ph.D. in Veterinary Health and Medicine at the Centre de Recerca en Sanitat Animal (CRESA), Barcelona, Spain. In February 2013, she moved to Sweden to work in human virology at the molecular virology division of Linköping University (LIU). In 2017, she joined INRAE, the French National Research Institute for Agriculture, Food and Environment in Jouy-en-Josas (Paris, France). Her current research address the virus-host interactions in porcine diseases with a focus on the Influenza virus and PRRSV and the use of pig as biomedical model.
